Product Code: ETC131333 | Publication Date: Jul 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The antidiabetics market in Thailand has witnessed significant growth in recent years, driven by the country`s increasing diabetic population and rising awareness of diabetes management. Diabetes mellitus, a chronic metabolic disorder, is a major public health concern in Thailand, with a growing number of patients requiring effective medications to manage their condition. The market for antidiabetic drugs includes a wide range of medications such as insulin, oral hypoglycemic agents, and injectable glucagon-like peptide-1 (GLP-1) receptor agonists, catering to different types and stages of diabetes.
Several drivers have contributed to the growth of the antidiabetics market in Thailand. Firstly, the prevalence of diabetes in the country has been rising due to factors such as changing lifestyles, sedentary habits, and unhealthy dietary patterns. As a result, there is an increasing demand for antidiabetic drugs to control blood glucose levels and prevent complications. Secondly, government initiatives and healthcare programs focusing on diabetes awareness and early detection have led to an increase in diagnosis rates, driving the demand for antidiabetic medications. Moreover, advancements in medical research and pharmaceutical development have resulted in the introduction of new and more effective antidiabetic drugs to the market.
Despite positive market trends, the antidiabetics industry in Thailand faces certain challenges. One of the key challenges is the high cost of some advanced antidiabetic medications, making them less accessible to some segments of the population. Additionally, ensuring proper adherence to treatment regimens can be challenging, as diabetes management often involves a combination of lifestyle changes and medication compliance. Furthermore, the presence of counterfeit or substandard antidiabetic drugs in the market poses a risk to patient safety and can undermine trust in the healthcare system.
The outbreak of the Covid-19 pandemic had an impact on the antidiabetics market in Thailand. With diabetes being a risk factor for severe Covid-19 outcomes, there was an increased focus on diabetes management and maintaining optimal glycemic control during the pandemic. Telemedicine and online consultations became more prevalent as a means to monitor and manage diabetes without risking exposure to the virus. However, disruptions in the supply chain and healthcare services during the early stages of the pandemic affected the availability and accessibility of antidiabetic drugs for some patients.
Thailand Antidiabetics |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Antidiabetics Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Antidiabetics Market Revenues & Volume, 2020 & 2027F |
3.3 Thailand Antidiabetics Market - Industry Life Cycle |
3.4 Thailand Antidiabetics Market - Porter's Five Forces |
3.5 Thailand Antidiabetics Market Revenues & Volume Share, By Product, 2020 & 2027F |
3.6 Thailand Antidiabetics Market Revenues & Volume Share, By Patient Population, 2020 & 2027F |
3.7 Thailand Antidiabetics Market Revenues & Volume Share, By Route of Administration, 2020 & 2027F |
4 Thailand Antidiabetics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Thailand Antidiabetics Market Trends |
6 Thailand Antidiabetics Market, By Types |
6.1 Thailand Antidiabetics Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Thailand Antidiabetics Market Revenues & Volume, By Product, 2018 - 2027F |
6.1.3 Thailand Antidiabetics Market Revenues & Volume, By InsulinΒ , 2018 - 2027F |
6.1.4 Thailand Antidiabetics Market Revenues & Volume, By Drug Class, 2018 - 2027F |
6.2 Thailand Antidiabetics Market, By Patient Population |
6.2.1 Overview and Analysis |
6.2.2 Thailand Antidiabetics Market Revenues & Volume, By Paediatric, 2018 - 2027F |
6.2.3 Thailand Antidiabetics Market Revenues & Volume, By Adult, 2018 - 2027F |
6.2.4 Thailand Antidiabetics Market Revenues & Volume, By Geriatric, 2018 - 2027F |
6.3 Thailand Antidiabetics Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Thailand Antidiabetics Market Revenues & Volume, By Insulin syringe/ Insulin pen, 2018 - 2027F |
6.3.3 Thailand Antidiabetics Market Revenues & Volume, By Insulin pump, 2018 - 2027F |
6.3.4 Thailand Antidiabetics Market Revenues & Volume, By Intravenous infusion, 2018 - 2027F |
6.3.5 Thailand Antidiabetics Market Revenues & Volume, By Oral, 2018 - 2027F |
6.3.6 Thailand Antidiabetics Market Revenues & Volume, By Others, 2018 - 2027F |
7 Thailand Antidiabetics Market Import-Export Trade Statistics |
7.1 Thailand Antidiabetics Market Export to Major Countries |
7.2 Thailand Antidiabetics Market Imports from Major Countries |
8 Thailand Antidiabetics Market Key Performance Indicators |
9 Thailand Antidiabetics Market - Opportunity Assessment |
9.1 Thailand Antidiabetics Market Opportunity Assessment, By Product, 2020 & 2027F |
9.2 Thailand Antidiabetics Market Opportunity Assessment, By Patient Population, 2020 & 2027F |
9.3 Thailand Antidiabetics Market Opportunity Assessment, By Route of Administration, 2020 & 2027F |
10 Thailand Antidiabetics Market - Competitive Landscape |
10.1 Thailand Antidiabetics Market Revenue Share, By Companies, 2020 |
10.2 Thailand Antidiabetics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |